MapLight Therapeutics (MPLT) general counsel Hanson sold 16,509 shares for $193K at $11.67 under a 10b5-1 plan
Insider transactions reported
Kristopher Hanson (General Counsel at MapLight Therapeutics Inc., MPLT) reported that they sold 16,509 shares for $193K at $11.67 on Sep 16, 2026. After these transactions the filing shows 137,044 shares held directly.
- Reporting person
- Hanson Kristopher
- Role
- General Counsel
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Open-market sale (S) | Voting Common Stock1, 2 | -16,509 | $11.67 | $193K | 137,044 direct |
Holdings before and after
- Voting Common Stock: 153,553 to 137,044 direct
Footnotes from the filing
- 1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.
- 2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.38 to $12.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
FAQ
What did Hanson report in this MPLT Form 4?
Kristopher Hanson (General Counsel at MapLight Therapeutics Inc., MPLT) reported that they sold 16,509 shares for $193K at $11.67 on Sep 16, 2026. After these transactions the filing shows 137,044 shares held directly.
How many MPLT shares does Hanson hold after this filing?
The filing shows 137,044 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this MPLT insider sale made under a 10b5-1 plan?
The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for MPLT
Across the 27 sessions after earlier MPLT headlines, the stock closed higher 19 times and lower 8 times, with a median move of 3.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | MPLT | SPY |
|---|---|---|---|
| Sep 9, 2026 | MapLight Therapeutics to Participate in Upcoming Investor Conference | -1.7% | -0.5% |
| Aug 14, 2026 | MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | +1.5% | -0.2% |
| Aug 13, 2026 | MapLight Therapeutics Announces $150 Million Private Placement Financing | +1.8% | +0.7% |
| Aug 10, 2026 | MapLight Therapeutics downgraded by UBS with a new price target | +0.1% | -0.0% |
| Jul 28, 2026 | MapLight Therapeutics downgraded by Morgan Stanley with a new price target | +24.3% | +0.2% |
| Jul 27, 2026 | MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia | -72.9% | +0.0% |
Earlier insider filings at MPLT
- Aug 19, 2026Chief Discovery Officer Kreitzer Anatol was granted 6,020 units of Voting Common Stock, increasing direct ownership by 3% to 180,926 units (SEC Form 4)
- Aug 19, 2026CAO and Interim CFO Gillis Jonathan was granted 8,242 units of Voting Common Stock, increasing direct ownership by 6% to 152,482 units (SEC Form 4)
- Aug 19, 2026Chief Executive Officer Kroeger Christopher A. was granted 23,145 units of Voting Common Stock, increasing direct ownership by 2% to 1,269,600 units (SEC Form 4)
- Aug 19, 2026General Counsel Hanson Kristopher was granted 7,730 units of Voting Common Stock, increasing direct ownership by 5% to 153,553 units (SEC Form 4)
- Aug 19, 2026Chief Medical Officer Foff Erin Pennock was granted 13,360 units of Voting Common Stock, increasing direct ownership by 4% to 312,261 units (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2025
Follow MPLT and get a push notification the moment its next story breaks.